{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:48:47Z","timestamp":1762541327160},"reference-count":37,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1185\/030079904125003269","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T23:17:31Z","timestamp":1082416651000},"page":"525-531","source":"Crossref","is-referenced-by-count":40,"title":["Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis"],"prefix":"10.1185","volume":"20","author":[{"given":"Lois E.","family":"Wehren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hosking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2004,2,19]]},"reference":[{"key":"CIT0001","first-page":"71","volume":"312","author":"Sackett DL","year":"1996","journal-title":"Richardson WS. Evidence based medicine:what it is and what it isn\u2019t. Br Med J"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7154.339"},{"key":"CIT0003","first-page":"1290","volume":"284","author":"Guyatt GH","year":"2000","journal-title":"XXV. Evidence-based medicine:principles for applying the users\u2019 guides to patient care. JAMA"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1007\/BF02441211"},{"key":"CIT0005","first-page":"291","volume":"19","author":"Ravn P","year":"1996","journal-title":"High bone turnover is associated with low bone mass in both preand postmenopausal women. Bone"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110307"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.8.1143"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00613-5"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1385\/JCD:2:3:323"},{"key":"CIT0011","first-page":"508","volume":"23","author":"Cranney A","year":"2002","journal-title":"Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev"},{"key":"CIT0012","first-page":"517","volume":"23","author":"Cranney A","year":"2002","journal-title":"Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev"},{"key":"CIT0013","first-page":"524","volume":"23","author":"Cranney A","year":"2002","journal-title":"Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev"},{"key":"CIT0014","first-page":"529","volume":"23","author":"Wells G","year":"2002","journal-title":"Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev"},{"key":"CIT0015","first-page":"540","volume":"23","author":"Cranney A","year":"2002","journal-title":"Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev"},{"key":"CIT0016","first-page":"570","volume":"23","author":"Cranney A","year":"2002","journal-title":"Summary of meta-analysis of therapies for postmenopausal osteoporosis. Endocr Rev"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(97)00049-8"},{"key":"CIT0018","first-page":"2829","volume":"283","author":"McAlister FA","year":"2000","journal-title":"Integrating research evidence with the care of the individual patient. JAMA"},{"key":"CIT0019","first-page":"488","volume":"21","author":"Song F","year":"2000","journal-title":"Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. Control Clin Trials"},{"key":"CIT0020","first-page":"472","volume":"326","author":"Song F","year":"2003","journal-title":"Validity of indirect comparison for estimating efficacy of competing interventions:empirical evidence from published meta-analyses. Br Med J"},{"key":"CIT0021","first-page":"496","volume":"23","author":"The Osteoporosis Methodology Group, The Osteoporosis Research Advisory Group","year":"2002","journal-title":"I. Systematic reviews of randomized trials in osteoporosis:introduction and methodology. Endocr Rev"},{"key":"CIT0022","first-page":"1371","volume":"282","author":"McAlister FA","year":"1999","journal-title":"XIX. Applying clinical trial results. B. Guidelines for determining whether a drug is exerting (more than) a class effect. JAMA"},{"key":"CIT0023","first-page":"556","volume":"11","author":"Cauley JA","year":"2000","journal-title":"Risk of mortality following clinical fractures. Osteoporos Int"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb02641.x"},{"key":"CIT0025","first-page":"721","volume":"15","author":"Klotzbuecher C","year":"2000","journal-title":"Berger M. Patients with prior fractures have an increased risk of future fractures:a summary of the literature and statistical synthesis. J Bone Miner Res"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6960.991"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.1.24"},{"issue":"4","key":"CIT0028","first-page":"S1\u2013S88","volume":"8","author":"National Osteoporosis Foundation","year":"1998","journal-title":"Osteoporos Int"},{"key":"CIT0029","first-page":"1367","volume":"272","author":"Oxman AD","year":"1994","journal-title":"Users\u2019 guides to the medical literature. VI. How to use an overview. JAMA"},{"key":"CIT0030","first-page":"1133","volume":"18","author":"Kanis JA","year":"2003","journal-title":"al. Study design in osteoporosis:a European perspective. J Bone Miner Res"},{"key":"CIT0031","first-page":"1783","volume":"85","author":"Downs RWJ","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0032","first-page":"505","volume":"55","author":"Dursin N","year":"2001","journal-title":"Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis. Int J Clin Pract"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125002009"},{"key":"CIT0035","first-page":"720","volume":"85","author":"Bone HG","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0036","first-page":"2525","volume":"289","author":"Greenspan SL","year":"2003","journal-title":"Parker RA. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women:a randomized controlled trial. JAMA"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-12-199912210-00005"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8415"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.1.6267"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079904125003269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T08:40:52Z","timestamp":1481618452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079904125003269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,19]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,1,22]]},"published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1185\/030079904125003269"],"URL":"https:\/\/doi.org\/10.1185\/030079904125003269","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,19]]}}}